Clinical Study About the Effects of Scuba Diving on Post Traumatic Stress Disorder (PTSD)
NCT ID: NCT04343924
Last Updated: 2024-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2023-02-07
2023-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study population will consist of patients monitored and treated for PTSD following the attacks of 14/07/2016 in Nice (France).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diving for Post Traumatic Stress Disorder (PTSD)
NCT03332290
Benefits of Diving Training on Recovery for Veterans Suffering of Chronic PTSD: an Exploratory Study
NCT03995992
Interest of Cardiac Coherence in the Prevention of Chronic Post-traumatic Stress Disorder: Pilot Study
NCT04701723
Benefits of Relaxation by Music Therapy on PTSD Symptoms
NCT03990064
A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder
NCT00978484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A matched group (gender, age, height, weight and BMI) will be composed of patients (n=12) who will not complete the Scuba Diving Discovery Course (GP- Virtual reality group). The subjects of this group will follow virtual reality sessions recreating the environment in which the scuba divers of the GP+ group operate. A control group (GT) will be composed of patients (n=12) who are monitored and treated for PTSD and who will not attend the dive discovery course or virtual reality sessions.
* The main evaluation criterion will be the NON-INVASIVE determination of salivary alpha amylase.
* Secondary evaluation criteria will be heart rate variation, CGI, HAD and BECK Anxiety, EGF, PCL-S and IES questionary.
The main objective is to study the effects of immersion and pressure relief ventilation on the activation of the autonomic parasympathetic nervous system.
Secondary objectives are to assess the symptomatic impact of parasympathetic autonomic nervous system activation on overall improvement, anxiety and depressive symptoms, functioning, and the 3 subtypes of PTSD symptoms as vegetative neuro hyperactivity, invasive syndrome and avoiding
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diving Group
The subjects of this group daily dive, 5 days per week, for a total of 10 dives at a maximum depth of 6 meters for a maximum duration of 20 minutes in a swimming pool.
Scuba diving activities
The subjects of this group daily dive, 5 days per week, for a total of 10 dives at a maximum depth of 6 meters for a maximum duration of 20 minutes in a swimming pool.
Virtual reality Group
The subjects of this group will follow virtual reality sessions recreating the environment in which the submarine diver of the GP+ group operates.
Virtual reality activities
The subjects of this group will follow virtual reality sessions recreating the environment in which the submarine diver of the GP+ group operates
Control Group
The subjects of this group will be monitored and treated for PTSD and will not attend the dive discovery course or virtual reality sessions.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scuba diving activities
The subjects of this group daily dive, 5 days per week, for a total of 10 dives at a maximum depth of 6 meters for a maximum duration of 20 minutes in a swimming pool.
Virtual reality activities
The subjects of this group will follow virtual reality sessions recreating the environment in which the submarine diver of the GP+ group operates
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who understand and read French
* Patients who have signed the informed consent form
* Patients who have never practiced scuba diving
* Patients medically fit for scuba diving
* Patients with the DSM-5 criteria for Post-traumatic Stress Disorder
* PCL-S score strictly greater than 44
* CGI greater than or equal to 4
* Chronicity (duration greater than 3 months)
Exclusion Criteria
* Pregnant or nursing women
* Patients under guardianship or curatorship and detainees of justice
* Patients who previously practised scuba diving or hold a diving certificate
* Patients whose medical condition medically contraindicated the practice of scuba diving,
* Patients having a water phobia, bipolar or psychotic disorder
* Patients with a severe and proven suicidal risk (MINI-S and medical examination)
* Patients treated for less than 2 months with antidepressants;
* Patients treated for less than 2 months with specific psychotherapy (Cognitive and Behavioural Therapy, EMDR)
* Patients with response to treatment (50% decrease in symptoms)
* Contraindications to the practice of virtual reality.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carl WILLEM
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nice
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-PP-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.